1,614 reports of this reaction
3.8% of all SOLIFENACIN SUCCINATE reports
#3 most reported adverse reaction
CONSTIPATION is the #3 most commonly reported adverse reaction for SOLIFENACIN SUCCINATE, manufactured by Astellas Pharma US, Inc.. There are 1,614 FDA adverse event reports linking SOLIFENACIN SUCCINATE to CONSTIPATION. This represents approximately 3.8% of all 42,941 adverse event reports for this drug.
Patients taking SOLIFENACIN SUCCINATE who experience constipation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONSTIPATION is moderately reported among SOLIFENACIN SUCCINATE users, representing a notable but not dominant share of adverse events.
In addition to constipation, the following adverse reactions have been reported for SOLIFENACIN SUCCINATE:
The following drugs have also been linked to constipation in FDA adverse event reports:
CONSTIPATION has been reported as an adverse event in 1,614 FDA reports for SOLIFENACIN SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONSTIPATION accounts for approximately 3.8% of all adverse event reports for SOLIFENACIN SUCCINATE, making it one of the most commonly reported side effect.
If you experience constipation while taking SOLIFENACIN SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.